Frontlight ResearchEarly access
Trial site
Uniwersytecki Szpital Kliniczny Nr 1 Im Norberta Barlickiego Uniwersytetu Medycznego W Lodzi SPZOZ
- 6running trials
- 8closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis4 trials
- Asthma2 trials
- Ulcerative colitis2 trials
- Chronic kidney disease1 trial
- COPD1 trial
- Hyperparathyroidism1 trial
- IgA nephropathy1 trial
- Multiple sclerosis1 trial
- Sarcoidosis1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Phase 1/21 trial
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Bristol-Myers Squibb Services Unlimited Company2 trials
- AstraZeneca1 trial
- Chiesi Farmaceutici S.p.A.1 trial
- Genentech Inc.1 trial
- HAL Allergy1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Sarcoidosis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Active, not recruiting
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026